Member Info for beechknot

Good interview .Do not understand why this selling already .all will take their own decisions for their money .

12.40 Paid .

Looking at number of sells .and looking at price .Have read gas is flowing for ANGS .

Rise long over due as with the news .Into time for news over to you D B and sales team .And NHS .

Move up time can it time to happen . GDR price dropped purchasers returning today .Can ncyt move up start again .

Lets be having a good day . Got distracted for a while watching gdr purchasers returning there after large price drop over time . ANGS has gas we have read .lets get cooking .

Friday rise on cards .Can another Friday 20% be seen again .

Some waited for 12p Purchase they picking them up .

Still expecting to be leaving soon with a nice profit
Operational highlights

· Significant diversification managed from predominantly fulfilling central government COVID-19 testing contracts to varied and fast-paced private COVID-19 testing market through relevant product launches (15 new assays) and innovative workflow solutions (including VersaLab™)

· Strengthened R&D capability whilst shifting focus to the post-COVID-19 portfolio and ensuring readiness for new In Vitro Diagnostic Regulation ("IVDR") in Europe effective from May 2022

· Complete integration of IT-IS International, following the acquisition in Q4 2020, supported an increase in the development of end-to-end testing solutions.

· Cemented Novacyt's position as "global first responder" with new contracts secured with WHO and UNICEF for the supply of COVID-19 products

· Key contract wins with major customers:

o Private test providers, including travel, sport, film, media, and workplace settings

o Inclusion in National Framework Agreement, resulting in a new £4.7m contract with the DHSC for the supply of PROmate® COVID-19 tests to the NHS

· David Allmond appointed as Chief Executive Officer alongside strengthened executive team and commercial operations to support future growth

Novacyt has also strengthened its position as an integrated reagent and instrument solution provider by signing an agreement with a leading global health provider to supply both instruments and reagents, for the detection of infectious diseases including high risk HPV and HIV, over a three year period.



Lastly, the Company has launched a new lateral flow test (LFT) reader for use in conjunction with a number of key assays within Novacyt's Pathflow® product portfolio. The small, lightweight LFT reader instrument is designed to provide digital test results based on optical imaging technology thereby removing the ambiguity of manually interpreting a positive/negative reading. The result is available in a matter of seconds (~10-12 secs) in a digital form that can be exported to other systems.

Good purchasing .Purchasers picking up shares again again today while price this low before next RNS .

After the so many purchases .Numerous purchasers look to have waited for their 12p buy in price .Expecting move back up with news due .

Seen it before .How many will start posting now they got purchase price this close to news due .

Some have now got their 12p target price before news .Can we now see a tick up . before next RNS .

Game so easy to read in September . SO close to time news due .

Deramps will never not get Me to sell this close to news .So easy to see game being played .

Expecting more of a move back up before end of day .To close to expected news time for some my guess .Seen this week number of purchases picking sells . How many of these purchases are derampers picking up lower priced shares before next RNS .

RNS due now September
http://www.genedriveplc.com ›
posted March 31st and now September almost six months in:
ANTICIPATED NEWS FLOW
<6 Months
• NHS updates on AIHL
• Updates on UK/I site adoptions of AIHL
• CoV-POC sales target updates
• Promotion and launch of AIHL assay in other EU countries
>6 Months
• Update on NICE guidelines for AIHL usage in emergency settings
• Consideration of US launch steps for AIHL
• Stroke marker test progress update and launch date confirmation

Also 42K purchase .

In March dropped to 12p before moving up .